Lung and colorectal cancer tissue test study
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This study checks a new way to prepare large tissue samples from lung or colorectal cancer for faster testing. It may help improve how tumors are analyzed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with lung cancer or colorectal cancer.
- Your medical records and tumor tissue samples (like slides, paraffin blocks, or leftover surgical tissue) must be available for the study.
- Your tissue samples must be complete and good quality for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study tests a new microscope that quickly analyzes lung tissue during a bronchoscopy or surgery. It may help doctors make faster, more accurate decisions about your care.
This study looks at genetic (DNA) and molecular (cell-level) information related to lung cancer to better understand the disease. You may be invited if you have a confirmed primary lung cancer diagnosis, or if you are healthy with no cancer.
This study looks for cancer-related material in blood, urine, and sometimes bone marrow. It may help researchers understand how to detect cancer activity and track it over time using less invasive tests.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This study looks at lung cancer tumor samples and blood to find DNA changes (gene changes) that may be driving the cancer. The results could help researchers better understand lung cancer and guide future treatments.
Hear when a new Lung Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.